{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:25:32Z","timestamp":1790940332281,"version":"4.1.0"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Nitroxide radicals are paramagnetic contrast agents, used in magnetic resonance imaging (MRI), that also exert antioxidant effects. Participating in cellular redox reactions, they lose their ability to provide contrast as a function of time after administration. In this study, the rate of contrast loss was correlated to the reducing power of the tissue or the \u201credox status.\u201d The preferential reduction of nitroxides in tumors compared with normal tissue was observed by MRI. The influence of the structure of the nitroxide on the reduction rate was investigated by MRI using two cell-permeable nitroxides, 4-hydroxy-2,2,6,6,-tetramethyl-1-piperidynyloxyl (Tempol) and 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-1-oxyl (3CP), and one cell-impermeable nitroxide, 3-carboxy-2,2,5,5,5-tetramethylpyrrolidine-1-oxyl (3CxP). Pharmacokinetic images of these nitroxides in normal tissue, tumor, kidney, and artery regions in mice were simultaneously obtained using MRI. The decay of Tempol and 3CP in tumor tissue was significantly faster than in normal tissue. No significant change in the total nitroxide (oxidized + reduced forms) was noted from tissue extracts, suggesting that the loss in contrast as a function of time is a result of intracellular bioreduction. However, in the case of 3CxP (membrane impermeable), there was no difference in the reduction rates between normal and tumor tissue. The time course of T1 enhancement by 3CxP and the total amount of 3CxP (oxidized + reduced) in the femoral region showed similar pharmacokinetics. These results show that the differential bioreduction of cell-permeable nitroxides in tumor and normal tissue is supported by intracellular processes and the reduction rates are a means by which the intracellular redox status can be assessed noninvasively. (Cancer Res 2006; 66(20): 9921-8)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-0879","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T09:42:10Z","timestamp":1161164530000},"page":"9921-9928","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":158,"title":["Probing the Intracellular Redox Status of Tumors with Magnetic Resonance Imaging and Redox-Sensitive Contrast Agents"],"prefix":"10.1158","volume":"66","author":[{"given":"Fuminori","family":"Hyodo","sequence":"first","affiliation":[{"name":"Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali C.","family":"Krishna","sequence":"additional","affiliation":[{"name":"Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,10,17]]},"reference":[{"key":"2022061622275766400_B1","doi-asserted-by":"crossref","unstructured":"Ronen SM, Leach MO. Imaging biochemistry: applications to breast cancer. Breast Cancer Res\u20082001; 3: 36\u201340.","DOI":"10.1186\/bcr268"},{"key":"2022061622275766400_B2","doi-asserted-by":"crossref","unstructured":"Bhujwalla ZM, Artemov D, Aboagye E, et al. The physiological environment in cancer vascularization, invasion and metastasis [discussion 45, 152\u20133]. Novartis Found Symp\u20082001; 240: 23\u201338.","DOI":"10.1002\/0470868716.ch3"},{"key":"2022061622275766400_B3","doi-asserted-by":"crossref","unstructured":"Bolan PJ, Nelson MT, Yee D, Garwood M. Imaging in breast cancer: magnetic resonance spectroscopy. Breast Cancer Res\u20082005; 7: 149\u201352.","DOI":"10.1186\/bcr1202"},{"key":"2022061622275766400_B4","doi-asserted-by":"crossref","unstructured":"Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging\u20082002; 16: 451\u201363.","DOI":"10.1002\/jmri.10172"},{"key":"2022061622275766400_B5","doi-asserted-by":"crossref","unstructured":"Bolan PJ, Meisamy S, Baker EH, et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med\u20082003; 50: 1134\u201343.","DOI":"10.1002\/mrm.10654"},{"key":"2022061622275766400_B6","doi-asserted-by":"crossref","unstructured":"Li X, Jin H, Lu Y, Oh J, Chang S, Nelson SJ. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed\u20082004; 17: 10\u201320.","DOI":"10.1002\/nbm.858"},{"key":"2022061622275766400_B7","doi-asserted-by":"crossref","unstructured":"Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide\/glutathione couple. Free Radic Biol Med\u20082001; 30: 1191\u2013212.","DOI":"10.1016\/S0891-5849(01)00480-4"},{"key":"2022061622275766400_B8","unstructured":"Kuppusamy P, Afeworki M, Shankar RA, et al. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Cancer Res\u20081998; 58: 1562\u20138."},{"key":"2022061622275766400_B9","unstructured":"Kuppusamy P, Li H, Ilangovan G, et al. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res\u20082002; 62: 307\u201312."},{"key":"2022061622275766400_B10","unstructured":"Beauregard DA, Hill SA, Chaplin DJ, Brindle KM. The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability. Cancer Res\u20082001; 61: 6811\u20135."},{"key":"2022061622275766400_B11","unstructured":"Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res\u20081998; 58: 1408\u201316."},{"key":"2022061622275766400_B12","doi-asserted-by":"crossref","unstructured":"Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer\u20082004; 4: 437\u201347.","DOI":"10.1038\/nrc1367"},{"key":"2022061622275766400_B13","doi-asserted-by":"crossref","unstructured":"Benard F, Turcotte E. Imaging in breast cancer: single-photon computed tomography and positron-emission tomography. Breast Cancer Res\u20082005; 7: 153\u201362.","DOI":"10.1186\/bcr1201"},{"key":"2022061622275766400_B14","doi-asserted-by":"crossref","unstructured":"Verreault J, Turcotte E, Benard F, Mongeau CJ, Boileau R. Extensive F-18 FDG uptake in metastatic spindle cell carcinoma of the lung. Clin Nucl Med\u20082001; 26: 79\u201380.","DOI":"10.1097\/00003072-200101000-00026"},{"key":"2022061622275766400_B15","doi-asserted-by":"crossref","unstructured":"Hayes C, Padhani AR, Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed\u20082002; 15: 154\u201363.","DOI":"10.1002\/nbm.756"},{"key":"2022061622275766400_B16","doi-asserted-by":"crossref","unstructured":"Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging\u20082002; 16: 407\u201322.","DOI":"10.1002\/jmri.10176"},{"key":"2022061622275766400_B17","doi-asserted-by":"crossref","unstructured":"Padhani AR, Leach MO. Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging. Abdom Imaging\u20082005; 30: 324\u201341.","DOI":"10.1007\/s00261-004-0265-5"},{"key":"2022061622275766400_B18","doi-asserted-by":"crossref","unstructured":"Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging\u20082003; 17: 509\u201320.","DOI":"10.1002\/jmri.10304"},{"key":"2022061622275766400_B19","doi-asserted-by":"crossref","unstructured":"Brasch RC, London DA, Wesbey GE, et al. Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology\u20081983; 147: 773\u20139.","DOI":"10.1148\/radiology.147.3.6844613"},{"key":"2022061622275766400_B20","doi-asserted-by":"crossref","unstructured":"Brasch RC, Nitecki DE, Brant-Zawadzki M, et al. Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report. AJR Am J Roentgenol\u20081983; 141: 1019\u201323.","DOI":"10.2214\/ajr.141.5.1019"},{"key":"2022061622275766400_B21","doi-asserted-by":"crossref","unstructured":"Hahn SM, Wilson L, Krishna CM, et al. Identification of nitroxide radioprotectors. Radiat Res\u20081992; 132: 87\u201393.","DOI":"10.2307\/3578338"},{"key":"2022061622275766400_B22","doi-asserted-by":"crossref","unstructured":"Samuni AM, DeGraff W, Krishna MC, Mitchell JB. Cellular sites of H2O2-induced damage and their protection by nitroxides. Biochim Biophys Acta\u20082001; 1525: 70\u20136.","DOI":"10.1016\/S0304-4165(00)00172-0"},{"key":"2022061622275766400_B23","doi-asserted-by":"crossref","unstructured":"Koretsky AP, Silva AC. Manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed\u20082004; 17: 527\u201331.","DOI":"10.1002\/nbm.940"},{"key":"2022061622275766400_B24","unstructured":"Keana JF, Pou S. Nitroxide-doped liposomes containing entrapped oxidant: an approach to the \u201creduction problem\u201d of nitroxides as MRI contrast agents. Physiol Chem Phys Med NMR\u20081985; 17: 235\u201340."},{"key":"2022061622275766400_B25","doi-asserted-by":"crossref","unstructured":"Matsumoto K, Hyodo F, Matsumoto A, et al. High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents. Clin Cancer Res\u20082006; 12: 2455\u201362.","DOI":"10.1158\/1078-0432.CCR-05-2747"},{"key":"2022061622275766400_B26","doi-asserted-by":"crossref","unstructured":"Mitchell JB, Russo A, Kuppusamy P, Krishna MC. Radiation, radicals, and images. Ann N Y Acad Sci\u20082000; 899: 28\u201343.","DOI":"10.1111\/j.1749-6632.2000.tb06174.x"},{"key":"2022061622275766400_B27","doi-asserted-by":"crossref","unstructured":"Krishna MC, Grahame DA, Samuni A, Mitchell JB, Russo A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci U S A\u20081992; 89: 5537\u201341.","DOI":"10.1073\/pnas.89.12.5537"},{"key":"2022061622275766400_B28","doi-asserted-by":"crossref","unstructured":"Krishna MC, Russo A, Mitchell JB, Goldstein S, Dafni H, Samuni A. Do nitroxide antioxidants act as scavengers of O2\u00b7. or as SOD mimics? J Biol Chem\u20081996; 271: 26026\u201331.","DOI":"10.1074\/jbc.271.42.26026"},{"key":"2022061622275766400_B29","doi-asserted-by":"crossref","unstructured":"Krishna MC, Samuni A, Taira J, Goldstein S, Mitchell JB, Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem\u20081996; 271: 26018\u201325.","DOI":"10.1074\/jbc.271.42.26018"},{"key":"2022061622275766400_B30","doi-asserted-by":"crossref","unstructured":"Goldstein S, Samuni A, Hideg K, Merenyi G. Structure-activity relationship of cyclic nitroxides as SOD mimics and scavengers of nitrogen dioxide and carbonate radicals. J Phys Chem A Mol Spectrosc Kinet Environ Gen Theory\u20082006; 110: 3679\u201385.","DOI":"10.1021\/jp056869r"},{"key":"2022061622275766400_B31","doi-asserted-by":"crossref","unstructured":"Dikalov S, Grigor'ev IA, Voinov M, Bassenge E. Detection of superoxide radicals and peroxynitrite by 1-hydroxy-4-phosphonooxy-2,2,6,6-tetramethylpiperidine: quantification of extracellular superoxide radicals formation. Biochem Biophys Res Commun\u20081998; 248: 211\u20135.","DOI":"10.1006\/bbrc.1998.8936"},{"key":"2022061622275766400_B32","doi-asserted-by":"crossref","unstructured":"Chen K, Glockner JF, Morse PD II, Swartz HM. Effects of oxygen on the metabolism of nitroxide spin labels in cells. Biochemistry\u20081989; 28: 2496\u2013501.","DOI":"10.1021\/bi00432a022"},{"key":"2022061622275766400_B33","doi-asserted-by":"crossref","unstructured":"Samuni Y, Gamson J, Samuni A, et al. Factors influencing nitroxide reduction and cytotoxicity in vitro. Antioxid Redox Signal\u20082004; 6: 587\u201395.","DOI":"10.1089\/152308604773934341"},{"key":"2022061622275766400_B34","doi-asserted-by":"crossref","unstructured":"Kuppusamy P, Chzhan M, Wang P, Zweier JL. Three-dimensional gated EPR imaging of the beating heart: time-resolved measurements of free radical distribution during the cardiac contractile cycle. Magn Reson Med\u20081996; 35: 323\u20138.","DOI":"10.1002\/mrm.1910350309"},{"key":"2022061622275766400_B35","doi-asserted-by":"crossref","unstructured":"Hahn SM, Krishna MC, DeLuca AM, Coffin D, Mitchell JB. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Free Radic Biol Med\u20082000; 28: 953\u20138.","DOI":"10.1016\/S0891-5849(00)00176-3"},{"key":"2022061622275766400_B36","doi-asserted-by":"crossref","unstructured":"Krishna MC, DeGraff W, Hankovszky OH, et al. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. J Med Chem\u20081998; 41: 3477\u201392.","DOI":"10.1021\/jm9802160"},{"key":"2022061622275766400_B37","unstructured":"Hahn SM, Krishna CM, Samuni A, et al. Potential use of nitroxides in radiation oncology. Cancer Res\u20081994; 54: 2006\u201310s."},{"key":"2022061622275766400_B38","doi-asserted-by":"crossref","unstructured":"Koscielniak J, Devasahayam N, Moni MS, et al. 300 MHz continuous wave electron paramagnetic resonance spectrometer for small animal in vivo imaging. Rev Sci Instrum\u20082000; 71: 4273\u201381.","DOI":"10.1063\/1.1318917"},{"key":"2022061622275766400_B39","doi-asserted-by":"crossref","unstructured":"Chen K, Morse PD II, Swartz HM. Kinetics of enzyme-mediated reduction of lipid soluble nitroxide spin labels by living cells. Biochim Biophys Acta\u20081988; 943: 477\u201384.","DOI":"10.1016\/0005-2736(88)90380-X"},{"key":"2022061622275766400_B40","unstructured":"Prescott DM, Charles HC, Poulson JM, et al. The relationship between intracellular and extracellular pH in spontaneous canine tumors. Clin Cancer Res\u20082000; 6: 2501\u20135."},{"key":"2022061622275766400_B41","doi-asserted-by":"crossref","unstructured":"Brown JM. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today\u20082000; 6: 157\u201362.","DOI":"10.1016\/S1357-4310(00)01677-4"},{"key":"2022061622275766400_B42","doi-asserted-by":"crossref","unstructured":"Kurhanewicz J, Vigneron DB, Hricak H, et al. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology\u20081996; 200: 489\u201396.","DOI":"10.1148\/radiology.200.2.8685346"},{"key":"2022061622275766400_B43","doi-asserted-by":"crossref","unstructured":"Swartz HM, Chen K, Pals M, Sentjurc M, Morse PD, II. Hypoxia-sensitive NMR contrast agents. Magn Reson Med\u20081986; 3: 169\u201374.","DOI":"10.1002\/mrm.1910030126"},{"key":"2022061622275766400_B44","doi-asserted-by":"crossref","unstructured":"Swartz HM, Sentjurc M, Morse PD II. Cellular metabolism of water-soluble nitroxides: effect on rate of reduction of cell\/nitroxide ratio, oxygen concentrations and permeability of nitroxides. Biochim Biophys Acta\u20081986; 888: 82\u201390.","DOI":"10.1016\/0167-4889(86)90073-X"},{"key":"2022061622275766400_B45","doi-asserted-by":"crossref","unstructured":"Yamada KI, Kuppusamy P, English S, et al. Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiol\u20082002; 43: 433\u201340.","DOI":"10.1034\/j.1600-0455.2002.430418.x"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/20\/9921\/2554926\/9921.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/20\/9921\/2554926\/9921.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:44:34Z","timestamp":1655430274000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/20\/9921\/526299\/Probing-the-Intracellular-Redox-Status-of-Tumors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,15]]},"references-count":45,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2006,10,17]]},"published-print":{"date-parts":[[2006,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-0879","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,15]]}}}